Galzin ® (zinc acetate capsules) is now available for maintenance treatment of patients with Wilson disease who have been initially treated with a chelating agent, according to Eton Pharmaceuticals.

IMPORTANT SAFETY INFORMATION Warning and Precautions Copper Deficiency: Several postmarketing cases reported that zinc acetate taken over extended periods of time (i.e., months to years) may result in ...

Optime Care, a nationally recognized specialty pharmacy and an AscellaHealth Company, today announces an expanded partnership with Eton Pharmaceuticals (“Eton”), an innovative pharmaceutical company ...

Eton Pharmaceuticals (NASDAQ:ETON) has acquired the drug Galzin, also known as zinc acetate, for the treatment of Wilson disease, an ultra-rare metabolic condition. Galzin is approved by the FDA ...

Copper Deficiency: Several postmarketing cases reported that zinc acetate taken over extended periods of time (i.e., months to years) may result in decreased enteral copper absorption and copper ...

The following adverse reactions associated with the use of zinc acetate were identified from postmarketing reports. Because these reactions were reported voluntarily from a population of uncertain ...